Recent studies in mouse models have demonstrated that Galectin-3 is involved in multiple inflammatory processes in diverse neurological diseases [83, 86] and that it promotes Aβ toxicity and oligomerization in AD [8, 87]. Here, LGALS3 is linked to nervous system disorder.